Clinical trial
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00165178 |
|---|---|
| Title | Treatment of Acute Lymphoblastic Leukemia in Children |
| Official title | Treatment of Acute Lymphoblastic Leukemia in Children |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Boston Children's Hospital University of Rochester McMaster University San Jorge Children's Hospital (Puerto Rico) St. Justine's Hospital Maine Children's Cancer Program Ochsner Health System Tulane… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | prednisone, dexamethasone, doxorubicin, E. coli asparaginase, vincristine, methotrexate, Leucovorin, Asparaginase, cytarabine, Methotrexate/Hydrocortisone |
| Enrollment | 498 |
| Start date | Sep 1, 2000 |
| Primary completion | Dec 1, 2004 |
| Completion | May 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Apr 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: